COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES

NCT05397795 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Infertility

Interventions

DRUG: 10000 IU hCG (Choriomon5000 IU; IBSA)
DRUG: Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring)

Sponsor

Alexandria University